Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 19 citing Gæde: Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention.... (0.12 sec) 

[PDF] A life in three parts


R PROHIBITED - pccj.eu
This quote rang a bell for me, because it is as true for general practice as it
was for Sir John Bland-Sutton in his surgical career. A recent response to
Professor Sir John Tooke's investigation into the 2007 junior doctors' ...
Related articles - View as HTML

Estimation of mortality savings due to a national program for diabetes care


J Dreiher, G Ginsberg, G Rabinowitz, A … - European Journal of Internal Medicine, 2009 - Elsevier
Total population data for Israel was projected to 2020. Current diabetes
prevalence and disease management data were obtained from a national program of
diabetes care. Projections of the program's effect were based on two ...
Related articles - All 16 versions

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists


KB Hansen, FK Knop, JJ Holst, T Vilsbøll - International Journal of Clinical Practice, 2009 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Related articles - All 3 versions

The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes …


MJ Postma, D de Zeeuw - Nephrology Dialysis Transplantation, 2009 - ERA-EDTA
The incidence of end-stage renal disease [ESRD; stage 5 chronic kidney disease
(CKD)] continues to increase in Europe, particularly due to type 2 diabetes,
hypertensive renovascular disease or atherosclerosis [1–3]. Indeed, ...
Related articles - All 5 versions

LWW Journals


MJ Postma, D de Zeeuw - Nephrology Dialysis Transplantation, 2009 - pt.wkhealth.com
The incidence of end-stage renal disease [ESRD; stage 5 chronic kidney disease
(CKD)] continues to increase in Europe, particularly due to type 2 diabetes,
hypertensive renovascular disease or atherosclerosis [1-3]. Indeed, across ...
Related articles

[PDF] Cystatin C as a marker of renal function in diabetic kidney disease


K Walczak, K Rośniak-Bąk, M Paradowski, D … - Age (years) - viamedica.pl
Abstract Background. Serum cystatin C is a new promising marker of renal
function. The aim of the study was to analyze serum cystatin C as a marker of
renal function in diabetes patients. Results. In 152 patients with type 1 ...
Related articles - View as HTML - All 2 versions

Appropriate, timely, and rational treatment of type 2 diabetes mellitus: Meeting the …

- insulinjournal.com [PDF] 
J Unger, CG Parkin - Insulin, 2009 - Elsevier
Diabetes now affects >24 million people in the United States. As the prevalence
of diabetes continues to increase, long-term complications of diabetes have
emerged as major health care issues. Although much focus has been placed on ...
Related articles - All 2 versions

Statement by an American Association of Clinical Endocrinologists/American College of …


HW Rodbard, PS Jellinger, JA Davidson, D … - Endocrine Practice, 2009 - AACE
Helena W. Rodbard, MD, FACP, MACE; Paul S. Jellinger, MD, MACE; Jaime A.
Davidson, MD, FACP, MACE; Daniel Einhorn, MD, FACP, FACE; Alan J. Garber, MD,
PhD, FACE; George Grunberger, MD, FACP, FACE; Yehuda Handelsman, MD, FACP, ...

Cost-effectiveness of Diabetes Self-management Programs in Community Primary Care …


CA Brownson, TJ Hoerger, EB Fisher, KE … - The Diabetes Educator, 2009 - tde.sagepub.com
Clinical results and costs were based on programs of the Diabetes Initiative of
the Robert Wood Johnson Foundation, implemented in primary care and community
settings in disadvantaged areas with notable health disparities. Program ...
Related articles - All 2 versions

[PDF] AACE/ACE Consensus Statement


HW Rodbard, PS Jellinger, JA Davidson, D … - ENDOCRINE PRACTICE, 2009 - spendocrinologia.org.pe
Helena W. Rodbard, MD, FACP, MACE; Paul S. Jellinger, MD, MACE; Jaime A.
Davidson, MD, FACP, MACE; Daniel Einhorn, MD, FACP, FACE; Alan J. Garber, MD,
PhD, FACE; George Grunberger, MD, FACP, FACE; Yehuda Handelsman, MD, FACP, ...
Related articles - View as HTML - All 2 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google